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ABSTRACT

Human lens proteins become progressively modified by tryptophan-derived UV
filter compounds in an age-dependent manner. Kynurenine, for example, undergoes
deamination at physiological pH, and the product binds covalently to the nucleophilic
residues in protein via a Michael addition. Key sites of kynurenine modification in
human lens proteins include cysteine, histidine and lysine residues.
The factors determining the levels of Kyn-amino acid adducts in vivo are not
known. An aim of this study was to determine the rate of reaction of Kyn with
nucleophilic amino acids (His, Cys and Lys) under physiological conditions (pH 7.2,
37˚C) and to evaluate the stability of the Kyn-amino acid adducts under these
conditions. Kinetic and stability studies were performed using both free amino acids and
modified calf lens protein, and reactions analysed by high performance liquid
chromatography and mass spectrometry.
Kinetic studies using free amino acids revealed that Cys reacted with Kyn at
approximately three times the rate of His and four times the rate of Lys. Kyn-t-Boc-His
was found to be the most stable of all the Kyn-amino acid adducts under physiological
conditions, followed by Kyn-t-Boc-Cys and Kyn-t-Boc-Lys.
Kyn-t-Boc-Lys and Kyn-Cys decomposed under physiological conditions,
releasing deaminated Kyn. Kyn-Cys was the least stable of the Kyn-amino acid adducts.
Incubation of Kyn-Cys in the presence of excess of t-Boc-L-His resulted in a decrease in
Kyn-Cys and a corresponding increase in Kyn-t-Boc-His, due to the transfer of
deaminated Kyn. Addition of a t-Boc group to the α-amino group of Cys increased the
stability of the Kyn-Cys adduct by a factor of three. Oxidation of Kyn-t-Boc-Cys to a
sulfoxide derivative decreased the stability by a factor of three.
Kinetic studies performed with calf lens protein incubated with Kyn showed that
Cys was the preferred site of Kyn modification, followed by His and Lys, repectively.
Following 14 days of incubation, Kyn-Cys was present at 12- and 17-fold greater levels
than Kyn-His and Kyn-Lys. Protein-bound Kyn-Cys appeared more stable than the free
Kyn-Cys adduct and was similar in stability to the free Kyn-t-Boc-Cys adduct. Under
these conditions, protein-bound Kyn-His levels increased by 38%, whereas Kyn-Lys
decreased by 28% with incubation time. Protein-bound Kyn-Lys was also relatively
more stable compared the free Kyn-amino acid adduct.
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Both the free amino acid and calf lens protein studies confirmed that Cys was
the best nucleophile at physiological pH, followed by His and Lys. Kyn-His, however,
was the most stable modification. The final pattern of Kyn-modification was shown to
be a factor of amino acid reactivity and stability rather than amino acid abundance.
Another aim of this study was to explore the hypothesis that protein-bound Kyn
is oxidised in the cataractous lens, as the levels of Kyn-His and Kyn-Lys decrease by a
factor of 4 with increasing severity of age-related nuclear (ARN) cataract.
Model studies were performed in which Kyn-t-Boc-His and Kyn-t-Boc-Lys
were incubated in the presence of an equimolar concentration of hydrogen peroxide.
These studies showed that hydrogen peroxide did not affect the decomposition of either
adduct under physiological conditions, suggesting that decomposition of these species
in the cataractous lens may be the result of other factors, for example, stronger oxidising
agents.
The final aim of this study was to investigate the photochemistry of proteinbound Kyn. Previous studies have shown that Kyn, when free in solution, is an
inefficient sensitizer of oxidative damage. However, the photochemistry of proteinbound UV filter molecules has not been investigated and this may be of significance,
especially for the older human lens, as a result of the decline in free Kyn and an increase
in the bound form.
Lens proteins covalently modified with kynurenine were susceptible to photooxidation by wavelengths of light that penetrate the cornea (UVA light λ>305, >345 and
>385 nm). These wavelengths were chosen because light in the 300-400 nm band are
absorbed by the lens. Hydrogen peroxide and protein-bound peroxides were found to
accumulate in a time-dependent manner after exposure to UV light (λ 305-385 nm),
with shorter wavelength light generating more peroxides. Peroxide formation was
accompanied by increases in the levels of protein-bound tyrosine oxidation products dityrosine and 3,4-dihydroxyphenylalanine, species known to be elevated in human
cataract lens proteins. Experiments using D2O, which enhances the lifetime of singlet
oxygen, and azide, a potent scavenger of this species, are consistent with oxidation
being mediated by singlet oxygen. These findings provide a mechanistic explanation of
UV light-mediated protein oxidation in cataract lenses, and also rationalise the
occurrence of age-related cataract in the nuclear region of the lens, as modification of
lens protein by UV filters occurs primarily in this region.
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